These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 34217065)

  • 1. Risk Factors Control and Early Recurrent Cerebral Infarction in Patients with Symptomatic Intracranial Atherosclerotic Disease.
    Del Brutto VJ; Liebeskind DS; Romano JG; Campo-Bustillo I; Cotsonis G; Nizam A; Prabhakaran S;
    J Stroke Cerebrovasc Dis; 2021 Sep; 30(9):105914. PubMed ID: 34217065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early aggressive medical management for patients with symptomatic intracranial stenosis.
    Nahab F; Kingston C; Frankel MR; Dion JE; Cawley CM; Mitchell B; Hammonds LP; Ayala L; Tong FC
    J Stroke Cerebrovasc Dis; 2013 Jan; 22(1):87-91. PubMed ID: 21795066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of Early Infarct Recurrence in Patients With Symptomatic Intracranial Atherosclerotic Disease.
    Prabhakaran S; Liebeskind DS; Cotsonis G; Nizam A; Feldmann E; Sangha RS; Campo-Bustillo I; Romano JG;
    Stroke; 2021 Jun; 52(6):1961-1966. PubMed ID: 33866818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between Risk Factor Control and Compliance with a Lifestyle Modification Program in the Stenting Aggressive Medical Management for Prevention of Recurrent Stroke in Intracranial Stenosis Trial.
    Turan TN; Al Kasab S; Nizam A; Lynn MJ; Harrell J; Derdeyn CP; Fiorella D; Janis LS; Lane BF; Montgomery J; Chimowitz MI;
    J Stroke Cerebrovasc Dis; 2018 Mar; 27(3):801-805. PubMed ID: 29169967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infarct Recurrence in Intracranial Atherosclerosis: Results from the MyRIAD Study.
    Romano JG; Prabhakaran S; Nizam A; Feldmann E; Sangha R; Cotsonis G; Campo-Bustillo I; Koch S; Rundek T; Chimowitz MI; Liebeskind DS;
    J Stroke Cerebrovasc Dis; 2021 Feb; 30(2):105504. PubMed ID: 33276302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of early Recurrence in Intracranial Atherosclerotic Disease (MyRIAD): Rationale and design.
    Liebeskind DS; Prabhakaran S; Azhar N; Feldmann E; Campo-Bustillo I; Sangha R; Koch S; Rundek T; Ostergren L; Chimowitz MI; Romano JG;
    J Stroke Cerebrovasc Dis; 2020 Oct; 29(10):105051. PubMed ID: 32912558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A survey on compliance with secondary stroke prevention guidelines and follow up for the inpatients with atherosclerotic cerebral infarction/transient ischemic attack.
    Ma R; Wang C; Zhao X; Xu M; Lv Y; Wei M; Cai Y; Zhang Z; Wang L; Zhang W; Huang Y; Li Y; Li H; Wang Y
    Neurol Res; 2008 May; 30(4):383-8. PubMed ID: 18544256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of Symptomatic Intracranial Stenosis.
    Hoak DA; Lutsep HL
    Curr Cardiol Rep; 2016 Sep; 18(9):83. PubMed ID: 27443379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current and future concepts in stroke prevention.
    O'Rourke F; Dean N; Akhtar N; Shuaib A
    CMAJ; 2004 Mar; 170(7):1123-33. PubMed ID: 15051698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Baseline Features and Risk Factor Control on Cognitive Function in the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis Trial.
    Turan TN; Al Kasab S; Smock A; Cotsonis G; Bachman D; Lynn MJ; Nizam A; Derdeyn CP; Fiorella D; Janis S; Lane B; Montgomery J; Chimowitz MI;
    Cerebrovasc Dis; 2019; 47(1-2):24-31. PubMed ID: 30763948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary prevention of atherothrombotic cerebrovascular events.
    Paciaroni M
    Curr Vasc Pharmacol; 2014 May; 12(3):365-72. PubMed ID: 24846225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrence risk in symptomatic intracranial stenosis treated medically in the real world.
    Yaghi S; Shu L; Goldstein ED; Chang A; Kala N; Stretz C; Burton TM; Perelstein E; Furie K; Jayaraman M; Torabi R; Moldovan K; de Havenon A; Khatri P; Gebregziabher M; Liebeskind DS; Prabhakaran S
    J Stroke Cerebrovasc Dis; 2023 Jun; 32(6):107086. PubMed ID: 37030126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognosis of Subtypes of Acute Large Artery Atherosclerotic Cerebral Infarction by Evaluation of Established Collateral Circulation.
    Gui X; Wang L; Wu C; Wang H; Kong J
    J Stroke Cerebrovasc Dis; 2020 Nov; 29(11):105232. PubMed ID: 33066931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical and lifestyle management of peripheral arterial disease.
    Parvar SL; Fitridge R; Dawson J; Nicholls SJ
    J Vasc Surg; 2018 Nov; 68(5):1595-1606. PubMed ID: 30360849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular risk factor control is insufficient in young patients with coronary artery disease.
    Christiansen MK; Jensen JM; Brøndberg AK; Bøtker HE; Jensen HK
    Vasc Health Risk Manag; 2016; 12():219-27. PubMed ID: 27307744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency, Risk Factors, and Outcome of Coexistent Small Vessel Disease and Intracranial Arterial Stenosis: Results From the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) Trial.
    Kwon HM; Lynn MJ; Turan TN; Derdeyn CP; Fiorella D; Lane BF; Montgomery J; Janis LS; Rumboldt Z; Chimowitz MI;
    JAMA Neurol; 2016 Jan; 73(1):36-42. PubMed ID: 26618534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Derivation and Application of a Tool to Estimate Benefits From Multiple Therapies That Reduce Recurrent Stroke Risk.
    Richards A; Jackson NJ; Cheng EM; Bryg RJ; Brown A; Towfighi A; Sanossian N; Barry F; Li N; Vickrey BG
    Stroke; 2020 May; 51(5):1563-1569. PubMed ID: 32200759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early and intermediate-term outcomes with drug-eluting stents in high-risk patients with symptomatic intracranial stenosis.
    Qureshi AI; Kirmani JF; Hussein HM; Harris-Lane P; Divani AA; Suri MF; Janjua N; Alkawi A
    Neurosurgery; 2006 Nov; 59(5):1044-51; discussion 1051. PubMed ID: 17143239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of vascular risk factors in the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST).
    Meschia JF; Voeks JH; Leimgruber PP; Mantese VA; Timaran CH; Chiu D; Demaerschalk BM; Howard VJ; Hughes SE; Longbottom M; Howard AG; Brott TG
    J Am Heart Assoc; 2014 Nov; 3(6):e001180. PubMed ID: 25428209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical risk factor treatment in peripheral arterial disease. Need for further improvement.
    Alhadad A; Wictorsson C; Alhadad H; Lindblad B; Gottsäter A
    Int Angiol; 2013 Jun; 32(3):332-8. PubMed ID: 23711686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.